Grupo Juste SAQF-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Grupo Juste SAQF - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011822
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Grupo Juste SAQF (Juste) discovers, develops and distributes pharmaceutical products and active pharmaceutical ingredients (APIs). It develops and manufactures oral and injectable radiological contrast media; antidepressants, oral contraceptives, prebiotic formulations for the prevention of fungal infections, primary care products and active pharmaceutical ingredients (APIs). Juste also offers services such as custom manufacturing, accelerated stability studies and research and development. It targets therapeutic areas of central nervous system, women’s health, radiology and primary care among others. The company has its operations in Europe, Asia, Australia, Africa and the Americas. Its manufacturing facility is located in Coslada, Spain. Juste is headquartered in Coslada, Spain.

Grupo Juste SAQF – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Grupo Juste SAQF, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Grupo Juste SAQF, Medical Devices Deals, 2011 to YTD 2017 9
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Grupo Juste to Enter into Licensing Agreement with RedHill Biopharma and IntelGenx 11
D&A Pharma Enters into Licensing Agreement with Grupo JUSTE 12
Asset Transactions 13
Exeltis Acquires Juste Farma Division from Juste labs 13
Grupo Juste SAQF – Key Competitors 14
Grupo Juste SAQF – Key Employees 15
Grupo Juste SAQF – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Key Facts 2
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Grupo Juste SAQF, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Grupo Juste SAQF, Deals By Therapy Area, 2011 to YTD 2017 8
Grupo Juste SAQF, Medical Devices Deals, 2011 to YTD 2017 9
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Grupo Juste to Enter into Licensing Agreement with RedHill Biopharma and IntelGenx 11
D&A Pharma Enters into Licensing Agreement with Grupo JUSTE 12
Exeltis Acquires Juste Farma Division from Juste labs 13
Grupo Juste SAQF, Key Competitors 14
Grupo Juste SAQF, Key Employees 15
Grupo Juste SAQF, Subsidiaries 16

★海外企業調査レポート[Grupo Juste SAQF-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a bio pharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematolog …
  • Franz Haniel & Cie. GmbH:企業の戦略・SWOT・財務分析
    Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report Summary Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • San Miguel Corp:企業の戦略・SWOT・財務情報
    San Miguel Corp - Strategy, SWOT and Corporate Finance Report Summary San Miguel Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Noble Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Noble Life Sciences Inc (Noble Life Sciences) is a contract research organization that offers drug, vaccine, and medical device development services. The company provides preclinical services such as analytical and laboratory services, disease and animal models, drug pharmacology and explora …
  • Lufthansa Cityline Gmbh:企業の戦略・SWOT・財務情報
    Lufthansa Cityline Gmbh - Strategy, SWOT and Corporate Finance Report Summary Lufthansa Cityline Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TSO3 Inc (TOS):企業の財務・戦略的SWOT分析
    TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Mphasis Limited:企業の戦略・SWOT・財務情報
    Mphasis Limited - Strategy, SWOT and Corporate Finance Report Summary Mphasis Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Principia Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase inhibitor. It …
  • Zoll Medical Corporation:企業の戦略的SWOT分析
    Zoll Medical Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Halozyme Therapeutics Inc (HALO):製薬・医療:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • Kimco Realty Corporation (KIM):企業の財務・戦略的SWOT分析
    Kimco Realty Corporation (KIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • China Daye Non-Ferrous Metals Mining Limited:企業の戦略・SWOT・財務情報
    China Daye Non-Ferrous Metals Mining Limited - Strategy, SWOT and Corporate Finance Report Summary China Daye Non-Ferrous Metals Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • The Howa Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Howa Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Howa Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • REVA Medical Inc (RVA):製品パイプライン分析
    Summary REVA Medical Inc (REVA) is a medical device company that develops minimally invasive medical devices. The company’s product includes bioresorbable polymers. Its bioresorbable polymers can be applied to a variety of medical applications. REVA’s fantom sirolimus-eluting bioresorbable scaffold …
  • The Siam Cement Public Co Ltd:企業の戦略・SWOT・財務分析
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Oriental Bank of Commerce:企業の戦略・SWOT・財務分析
    Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report Summary Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Oragenics Inc (OGEN):企業の財務・戦略的SWOT分析
    Oragenics Inc (OGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Blue Energy Ltd (BUL):石油・ガス:M&Aディール及び事業提携情報
    Summary Blue Energy Ltd (BEL) is an oil and gas company that provides exploration and development services. The company provides exploration and production of coal seam gas and conventional oil, and gas resources in Australia. Its projects portfolio includes carpentaria basin, bowen basin, galilee b …
  • Trinity Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Trinity Health (Trinity) formerly known as CHE Trinity Health, is a national Catholic health care organization that provides health care solutions in the US. It operates through a network of hospitals, health care services, and advocate partnerships at community, regional, and national level …
  • Oil and Natural Gas Corp Ltd (ONGC):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil and Natural Gas Corp Ltd (ONGC) is an integrated energy company, operating along the hydrocarbon value chain. It discovers, produces, refines and markets oil and gas, and also manufactures petrochemicals. The company also conducts power generation and has considerable renewable energy op …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆